» Articles » PMID: 36478827

Incidence and Predictors of Tuberculosis Among Children on Antiretroviral Therapy at Northeast Ethiopia Comprehensive Specialized Hospitals, 2022; A Multicenter Retrospective Follow-up Study

Overview
Journal Heliyon
Specialty Social Sciences
Date 2022 Dec 8
PMID 36478827
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Around the world, tuberculosis (TB) is the most common cause of mortality and morbidity in both adults and children. The incidence of tuberculosis (TB) is increased worldwide by co-infection with the human immunodeficiency virus (HIV), particularly in Sub-Saharan Africa. As a result, the study aimed to determine the incidence and predictors of tuberculosis among children on antiretroviral therapy at northeast Ethiopia Comprehensive Specialized Hospitals.

Methods: An institution-based retrospective follow-up study was carried out in northeast Ethiopia's Comprehensive Specialized Hospitals, among 362 children on antiretroviral therapy from January 1, 2007, to September 30, 2021. The data were entered into Epi Data version 4.6.1 and then exported to STATA version 16 for analysis. Bivariate and multivariable Cox proportional hazards model was used to discover tuberculosis predictors. Variables with a p-value of <0.05 at 95% confidence intervals in the multivariable Cox proportional hazard model were considered statistically significant.

Results: Among the 358 Human Immunodeficiency Virus-infected children, two-thirds (69.3%) were over ten years old. The overall tuberculosis incidence rate was 2.0 (95%CI: 1.5-2.6) per 100 person-years with a total of 2452 years of observations. WHO clinical stages III and IV [AHR: 3.2 (95% CI 1.8-5.5)], being severely stunted [AHR = 2.1 (95% CI, 1.5-358)], and "Fair" and "poor" adherence levels to antiretroviral therapy [AHR = 4.0 (95% CI 1.5-10.8)] were independent predictors of tuberculosis.

Conclusion: The incidence of tuberculosis in children infected with HIV/AIDS was high in this study. The risk of tuberculosis (TB) in HIV/AIDS-infected children has been linked to WHO stages III and IV, severe stunting, and "Fair" and "Poor" ART adherence. As a result, children with HIV/ADIS should be evaluated on a regular basis in order to improve the quality of ART services and reduce the incidence rate of tuberculosis among children.

Citing Articles

Incidence of tuberculosis and its predictors among children on antiretroviral therapy in Amhara Region, Ethiopia: a multicentre institution-based retrospective follow-up study.

Mekonnen G, Legesse B, Baye F, Wondie W BMJ Open. 2025; 15(2):e093808.

PMID: 39947830 PMC: 11831273. DOI: 10.1136/bmjopen-2024-093808.


Proportion of active tuberculosis among HIV-infected children after antiretroviral therapy in Ethiopia: A systematic review and meta-analysis.

Bizuneh F, Tsegaye D, Negese Gemeda B, Bizuneh T PLOS Glob Public Health. 2024; 4(8):e0003528.

PMID: 39093892 PMC: 11296650. DOI: 10.1371/journal.pgph.0003528.


Incidence and predictors of tuberculosis among HIV-infected children after initiation of antiretroviral therapy in Ethiopia: A systematic review and meta-analysis.

Kassaw A, Asferie W, Azmeraw M, Kefale D, Kerebih G, Mekonnen G PLoS One. 2024; 19(7):e0306651.

PMID: 38968268 PMC: 11226042. DOI: 10.1371/journal.pone.0306651.


Incidence rate of tuberculosis among HIV infected children in Ethiopia: systematic review and meta-analysis.

Girma D, Abita Z, Shifera N, Arage M, Abate B, Alie M BMC Pediatr. 2024; 24(1):363.

PMID: 38790006 PMC: 11127285. DOI: 10.1186/s12887-024-04819-7.


Active tuberculosis incidence among treatment failure experienced patients in North Wollow Zone: A multicenter historical cohort.

Bizuneh F, Masresha S, Yayeh B, Bizuneh T Health Sci Rep. 2024; 7(4):e1997.

PMID: 38562614 PMC: 10982461. DOI: 10.1002/hsr2.1997.

References
1.
Fry S, Barnabas S, Cotton M . Tuberculosis and HIV-An Update on the "Cursed Duet" in Children. Front Pediatr. 2020; 7:159. PMC: 7073470. DOI: 10.3389/fped.2019.00159. View

2.
Petersen E, Al-Abri S, Chakaya J, Goletti D, Parolina L, Wejse C . World TB Day 2022: Revamping and Reshaping Global TB Control Programs by Advancing Lessons learnt from the COVID-19 pandemic. Int J Infect Dis. 2022; 124 Suppl 1:S1-S3. PMC: 8894685. DOI: 10.1016/j.ijid.2022.02.057. View

3.
Chakaya J, Khan M, Ntoumi F, Aklillu E, Fatima R, Mwaba P . Global Tuberculosis Report 2020 - Reflections on the Global TB burden, treatment and prevention efforts. Int J Infect Dis. 2021; 113 Suppl 1:S7-S12. PMC: 8433257. DOI: 10.1016/j.ijid.2021.02.107. View

4.
Semu M, Gedif Fenta T, Medhin G, Assefa D . Effectiveness of isoniazid preventative therapy in reducing incidence of active tuberculosis among people living with HIV/AIDS in public health facilities of Addis Ababa, Ethiopia: a historical cohort study. BMC Infect Dis. 2017; 17(1):5. PMC: 5209939. DOI: 10.1186/s12879-016-2109-7. View

5.
Aung Z, Saw Y, Saw T, Oo N, Aye H, Aung S . Survival rate and mortality risk factors among TB-HIV co-infected patients at an HIV-specialist hospital in Myanmar: A 12-year retrospective follow-up study. Int J Infect Dis. 2018; 80:10-15. DOI: 10.1016/j.ijid.2018.12.008. View